A total of 13 products were added in the month from 10 different asset managers: Veritas, Credicorp Capital, Global X, Jupiter, RAMS, Bain Capital, Copenhagen Infrastructure Partners, I Squared Capital, One Equity Partners and Revcap.
CCR Monthly Approval Report – January 2025
February 3, 2025 by
Sponsors gaining approval were Schroders, Ishares, Invesco, Nomura, Pamlico and Permira.
CCR Monthly Approval Report – December 2024
January 9, 2025 by
Comgest, Lord Abbett, Jupiter, BC Partners and Novacap were the fund sponsors gaining approval for new product.
CCR Monthly Approval Report – November 2024
December 3, 2024 by
A total of 10 products were added in the month from the following asset managers: Franklin Templeton, Mirae, Antares Capital, Bain Capital, Intermediate CP, K1 Investment Management and Oakley Capital.
CCR Monthly Approval Report – October 2024
November 4, 2024 by
A total of five products were added in the month from four different asset managers: iShares, T. Rowe Price, Comvest Partners and NB Alternatives.
CCR Monthly Approval Report – September 2024
October 1, 2024 by
Polar Capital, DigitalBridge and Thomas H. Lee Partners were the managers registering products in September 2024.
CCR Monthly Approval Report – August 2024
September 4, 2024 by
Janus Henderson, Fidelity, Lazard, Muzinich, HarbourVest, Kohlberg & Co, Nautic and PSG Equity were the fund sponsors gaining approval for new products in August.
CCR Monthly Approval Report – July 2024
August 8, 2024 by
A total of 19 products were added in the month from nine different asset managers: BNP Paribas, BNY Mellon, Fidelity, First Sentier, Franklin Templeton, LarrainVial, PIMCO, Summit Partners and UBS.
CCR Monthly Approval Report – June 2024
July 2, 2024 by
JPMorgan led with five ETFs, followed by Allianz, Bluebay, Comgest, Man and Morgan Stanley each with one mutual fund approved. Two alternative products also got the green light, one from Hollyport Capital and one from Rivean Capital.
CCR Monthly Approval Report – May 2024
June 3, 2024 by
BNP Paribas, Credicorp Capital, JP Morgan, Morgan Stanley, PIMCO, Theam Quant, Eurazeo and Kinderhook were the fund sponsors gaining approval for new products.
